Oriola-KD:s interim report 1 july - 30 September 2006

Oriola-KD Corporation stock exchange release 1 November 2006 at 8.35 am

Oriola-KD Corporation was listed on the Helsinki Exchanges on 3 July 2006. This
interim report presents Oriola-KD Corporation's (Oriola-KD) figures for
July-September 2006. The figures for Oriola-KD's period under review have been
prepared in accordance with the recognition and valuation principles of the
IFRS standards and the figures are unaudited. Oriola-KD Corporation has
published on 1 November 2006 pro forma review from January-September 2006
including complementary information to this interim report. The July-September
2006 figures are different from the pro forma figures due to different
financial periods with different foreign exchange rates. 

Key figures

Invoicing in the period was EUR 562.8 million and net sales were EUR 318.9
million 
Operating profit excluding one-off items was EUR 7.2 million
Operating profit including one-off items was EUR 6.8 million
Cash flow from operations was EUR 21.1 million
Return on capital employed (ROCE) was 13.5 per cent
Earnings per share were EUR 0.04


Future outlook

Oriola-KD's outlook for 2006 is based on external market forecasts, agreements
with principals, cumulative orders and management's estimates. 

Finnish pharmaceutical market growth is estimated to be flat in 2006. Swedish
pharmaceutical market is estimated to grow by 4-5 per cent in 2006. Long term
fundamentals and growth prospects are deemed favourable. Oriola-KD estimates
that the longer term pharmaceutical market will grow by about 3-5 per cent in
Finland and Sweden over the next few years, which is in line with the average
growth rate of these markets. 

The overall objective of the cost efficiency measures that were launched in the
early part of 2006 is to achieve total savings of some five million euros
annually in the Group's operations in Finland and Sweden, with full impact as
of 2007. The one-off items of the cost efficiency measures are estimated to be
about EUR 3 million and they will occur in 2006. 

Oriola-KD estimates that the market for healthcare and dental equipment and
supplies will grow by more than 5 per cent in Finland and Sweden in 2006. In
sales of healthcare equipment and supplies, Oriola-KD estimates that its growth
will outpace that of the market. The dental trade is expected to grow at a rate
slower than market growth. Invoicing for the healthcare logistics services in
Sweden is estimated to be at the previous year's level. 

Oriola-KD's pro forma invoicing in 2006 is forecast to be nearly at the level
of the previous year's comparable invoicing. The pro forma operating profit for
2006 is forecast to be lower than the previous year's comparable operating
profit, owing mainly to the tight competitive situation within pharmaceutical
distribution and trade and the slow growth in Finland's pharmaceutical market
in the early part of the year as well as one-off expenses for the demerger and
the reorganisation of functions. 


Espoo, 1 November 2006

Oriola-KD Corporation's Board of Directors

Oriola-KD Corporation


Eero Hautaniemi
President and CEO

Kimmo Virtanen
CFO

For additional information, contact:

Eero Hautaniemi
President and CEO
tel. +358 10 429 2109
email: eero.hautaniemi@oriola-kd.com

Kimmo Virtanen
CFO
tel. +358 10 429 2069
email: kimmo.virtanen@oriola-kd.com


Pellervo Hämäläinen
Vice President, Communications and IR
tel. +358 10 429 2497
email: pellervo.hamalainen@oriola-kd.com

Distribution
Helsinki Stock Exchange
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Harmaaparrankuja 1
FI-02200 Espoo
www.oriola-kd.com

The full report including tables can be downloaded from the following link:


Oriola-KD:s interim report 1 July - 30 September 2006